+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 72 Pages
  • May 2024
  • GlobalData
  • DaVita Inc
  • ID: 4189021
DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DaVita Inc (DaVita) provides dialysis services and integrated health care management services. The company caters to patients with chronic kidney failure and end-stage renal disease (ESRD). It offers various ancillary services, including therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. It has an operational presence in Arizona, California, Nevada, Florida, New Mexico, and Colorado. DaVita is headquartered in Denver, Colorado, the US.

DaVita Inc Key Recent Developments

  • May 02, 2024: DaVita Announces 1st Quarter 2024 Results
  • Apr 22, 2024: DaVita's Global Operations Powered by 100% Renewable Energy
  • Apr 17, 2024: DaVita Schedules 1st Quarter 2024 Investor Conference Call
  • Apr 10, 2024: DaVita Announces Dennis Pullin to its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • DaVita Inc - Key Facts
  • DaVita Inc - Key Employees
  • DaVita Inc - Key Employee Biographies
  • DaVita Inc - Major Products and Services
  • DaVita Inc - History
  • DaVita Inc - Company Statement
  • DaVita Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • DaVita Inc - Business Description
  • Business Segment: Other-Ancillary Services
  • Overview
  • Performance
  • Business Segment: U.S. Dialysis
  • Overview
  • Performance
  • Key Stats
  • DaVita Inc - Corporate Strategy
  • DaVita Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • DaVita Inc - Strengths
  • DaVita Inc - Weaknesses
  • DaVita Inc - Opportunities
  • DaVita Inc - Threats
  • DaVita Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • DaVita Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • DaVita Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 02, 2024: DaVita Announces 1st Quarter 2024 Results
  • Apr 22, 2024: DaVita's Global Operations Powered by 100% Renewable Energy
  • Apr 17, 2024: DaVita Schedules 1st Quarter 2024 Investor Conference Call
  • Apr 10, 2024: DaVita Announces Dennis Pullin to its Board of Directors
  • Mar 05, 2024: Davita Enters into Agreement to Expand Operations in Brazil and Colombia, Enter Chile and Ecuador
  • Jan 23, 2024: DaVita Schedules 4th Quarter 2023 Investor Conference Call
  • Nov 07, 2023: DaVita Announces 3rd Quarter 2023 Results
  • Oct 17, 2023: DaVita Schedules 3rd Quarter 2023 Investor Conference Call
  • Sep 13, 2023: Davita Launches Community Health Tour to Provide Free Kidney Screenings and Education Coast-To-Coast
  • Aug 03, 2023: DaVita Reports 2nd Quarter 2023 Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • DaVita Inc, Key Facts
  • DaVita Inc, Key Employees
  • DaVita Inc, Key Employee Biographies
  • DaVita Inc, Major Products and Services
  • DaVita Inc, History
  • DaVita Inc, Other Locations
  • DaVita Inc, Subsidiaries
  • DaVita Inc, Joint Venture
  • DaVita Inc, Key Competitors
  • DaVita Inc, Ratios based on current share price
  • DaVita Inc, Annual Ratios
  • DaVita Inc, Annual Ratios (Cont...1)
  • DaVita Inc, Annual Ratios (Cont...2)
  • DaVita Inc, Interim Ratios
  • DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • DaVita Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • DaVita Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • DaVita Inc, Performance Chart (2019 - 2023)
  • DaVita Inc, Ratio Charts
  • DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • DaVita Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Satellite Healthcare Inc
  • Northwest Kidney Centers
  • Fresenius Medical Care AG & Co KGaA
  • Dialysis Corp of America
  • Baxter International Inc